TTM
$20.74B
YoY change
+90.6%
5Y CAGR
+12.7%
Peak year (2023)
$35.15B
Cumulative net income
$384.33B
Net Income history chart for Johnson & Johnson (JNJ) from 1985 to 2025
Latest: $26.80B
Net Income growth chart for Johnson & Johnson (JNJ) from 1985 to 2025
Latest: +90.6%
Net Income history table for Johnson & Johnson (JNJ) from 1985 to 2025
| 2025 | $26.80B | +90.6% | +$12.74B | ||
| 2024 | $14.07B | -60.0% | −$21.09B | ||
| 2023 | $35.15B | +95.9% | +$17.21B | ||
| 2022 | $17.94B | -14.1% | −$2.94B | ||
| 2021 | $20.88B | +41.9% | +$6.16B | ||
| 2020 | $14.71B | -2.7% | −$405.00M | ||
| 2019 | $15.12B | -1.2% | −$178.00M | ||
| 2018 | $15.30B | +1076.7% | +$14.00B | ||
| 2017 | $1.30B | -92.1% | −$15.24B | ||
| 2016 | $16.54B | +7.3% | +$1.13B | ||
| 2015 | $15.41B | -5.6% | −$914.00M | ||
| 2014 | $16.32B | +18.0% | +$2.49B | ||
| 2013 | $13.83B | +27.4% | +$2.98B | ||
| 2012 | $10.85B | +12.2% | +$1.18B | ||
| 2011 | $9.67B | -27.5% | −$3.66B | ||
| 2010 | $13.33B | +8.7% | +$1.07B | ||
| 2009 | $12.27B | -5.3% | −$683.00M | ||
| 2008 | $12.95B | +22.4% | +$2.37B | ||
| 2007 | $10.58B | -4.3% | −$477.00M | ||
| 2006 | $11.05B | +9.9% | +$993.00M | ||
| 2005 | $10.06B | +23.0% | +$1.88B | ||
| 2004 | $8.18B | +13.7% | +$983.00M | ||
| 2003 | $7.20B | +9.1% | +$600.00M | ||
| 2002 | $6.60B | +16.4% | +$929.00M | ||
| 2001 | $5.67B | +14.4% | +$715.00M | ||
| 2000 | $4.95B | +15.9% | +$680.00M | ||
| 1999 | $4.27B | +42.3% | +$1.27B | ||
| 1998 | $3.00B | -9.1% | −$300.00M | ||
| 1997 | $3.30B | +14.4% | +$416.00M | ||
| 1996 | $2.89B | +20.1% | +$484.00M | ||
| 1995 | $2.40B | +19.8% | +$397.00M | ||
| 1994 | $2.01B | +12.3% | +$219.00M | ||
| 1993 | $1.79B | +73.5% | +$757.00M | ||
| 1992 | $1.03B | -29.5% | −$431.00M | ||
| 1991 | $1.46B | +27.8% | +$318.00M | ||
| 1990 | $1.14B | +5.6% | +$61.00M | ||
| 1989 | $1.08B | +11.1% | +$108.00M | ||
| 1988 | $974.00M | +16.9% | +$141.00M | ||
| 1987 | $833.00M | +152.8% | +$503.50M | ||
| 1986 | $329.50M | -46.3% | −$284.20M | ||
| 1985 | $613.70M | — | — |
- 2025$26.80B+90.6%
- 2024$14.07B-60.0%
- 2023$35.15B+95.9%
- 2022$17.94B-14.1%
- 2021$20.88B+41.9%
- 2020$14.71B-2.7%
- 2019$15.12B-1.2%
- 2018$15.30B+1076.7%
- 2017$1.30B-92.1%
- 2016$16.54B+7.3%
- 2015$15.41B-5.6%
- 2014$16.32B+18.0%
- 2013$13.83B+27.4%
- 2012$10.85B+12.2%
- 2011$9.67B-27.5%
- 2010$13.33B+8.7%
- 2009$12.27B-5.3%
- 2008$12.95B+22.4%
- 2007$10.58B-4.3%
- 2006$11.05B+9.9%
- 2005$10.06B+23.0%
- 2004$8.18B+13.7%
- 2003$7.20B+9.1%
- 2002$6.60B+16.4%
- 2001$5.67B+14.4%
- 2000$4.95B+15.9%
- 1999$4.27B+42.3%
- 1998$3.00B-9.1%
- 1997$3.30B+14.4%
- 1996$2.89B+20.1%
- 1995$2.40B+19.8%
- 1994$2.01B+12.3%
- 1993$1.79B+73.5%
- 1992$1.03B-29.5%
- 1991$1.46B+27.8%
- 1990$1.14B+5.6%
- 1989$1.08B+11.1%
- 1988$974.00M+16.9%
- 1987$833.00M+152.8%
- 1986$329.50M-46.3%
- 1985$613.70M—
Net Income values are taken from Johnson & Johnson's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current net income (TTM) is $20.74B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual net income for Johnson & Johnson (JNJ) came in at $26.80B – surged 90.6% year-over-year.
Johnson & Johnson net income compound annual growth for the 2020–2025 (5 years) window is +12.7%, with mixed annual results across the window.
Johnson & Johnson net income declined from $35.15B in 2023 to $26.80B in 2025, a 23.8% drawdown.
2023 marks the peak net income at $35.15B, with the historical low of $329.50M recorded in 1986.
Johnson & Johnson Net Income by Year
Johnson & Johnson Net Income 2025: $26.80B
Johnson & Johnson posted net income of $26.80B in 2025, surged 90.6% from 2024.
Johnson & Johnson Net Income 2024: $14.07B
In 2024, Johnson & Johnson reported net income of $14.07B, plunged 60.0% below 2023.
Johnson & Johnson Net Income 2023: $35.15B
Johnson & Johnson net income in 2023 was $35.15B, surged 95.9% from 2022. This figure represents the highest annual value in the available history.
Johnson & Johnson Net Income 2022: $17.94B
2022's net income for Johnson & Johnson came in at $17.94B, declined 14.1% below 2021.
Johnson & Johnson Net Income 2021: $20.88B
Johnson & Johnson net income in 2021 was $20.88B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers by Net Income
Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest net income
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $6.74B | |
| $4.23B |
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation